VYNE THERAPEUTICS INC. (VYNE) Shareholders’ equity 2016–2025
VYNE THERAPEUTICS INC. (VYNE) shareholders’ equity at each fiscal year-end, per SEC filings.
$27.8MFY2025 · since FY2016: -$29.4M → $27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.8M | -46.7% |
| FY2024 | $52.1M | -41.3% |
| FY2023 | $88.7M | +184.4% |
| FY2022 | $31.2M | -35.8% |
| FY2021 | $48.6M | +29.7% |
| FY2020 | $37.5M | +113.3% |
| FY2019 | $17.6M | -80.9% |
| FY2018 | $92.2M | +34.4% |
| FY2017 | $68.6M | +333.0% |
| FY2016 | -$29.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice